Cambridge Enterprise

TRIMTECH Therapeutics is a biotechnology company focused on developing targeted protein degradation therapies to treat neurodegenerative diseases. Their innovative platform aims to degrade toxic protein aggregates, offering oral therapeutics with high specificity, a strong safety profile, and potential for personalized treatment approaches. This enables patients to access effective and safe treatments for neurological, inflammatory, and oncological conditions.

Illumion is a technology company specializing in energy storage solutions. It develops and manufactures a lab-based, real-time measurement device that provides detailed insights into energy storage processes at sub-micrometer scales. This device enables researchers to visualize and understand energy storage processes in real-time, optimize material usage, and identify performance limitations at the microscopic level, thereby accelerating battery development and enhancing energy storage efficiency and performance.

52 North Health develops an AI-powered medical device for determining neutropenic sepsis risk in chemotherapy patients. Its portable finger-prick blood test measures neutrophil count and C-Reactive Protein (CRP) levels at home, enabling early detection and improved management of this fatal side effect.

AllFocal Optics specializes in nanophotonic technology for display enhancement. Its innovative solutions aim to provide natural visual clarity and comfort, addressing physical discomforts such as headaches associated with current AR/VR glasses.

Upfront Diagnostics specializes in the development of rapid diagnostic tests for stroke identification using blood biomarkers. Their innovative approach enables emergency medical professionals to detect large vessel occlusion strokes within minutes, leading to faster and more accurate diagnoses, improved patient outcomes, and reduced healthcare costs.